Insider · CIK 0001035443
Alexandria Real Estate Equities, Inc.
Files at APLT (Applied Therapeutics, Inc.). First filing Nov 2, 2023, latest Jun 6, 2024.
In brief
Alexandria Real Estate Equities, Inc. files SEC Form 4 as 10% owner at APLT (Applied Therapeutics, Inc.). Since Nov 2, 2023, Alexandria Real Estate Equities, Inc. has reported 0 open-market buys worth $0 and 3 open-market sells worth $2.6M, the latest filed on Jun 6, 2024.
A track record needs three past buys with six months of prices behind them; Alexandria Real Estate Equities, Inc. has 0, so none is measured yet.
The newest scored trade: sold $1.3M of APLT on Jun 4, 2024, filed Jun 6, 2024, scored 52 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | Applied Therapeutics, Inc. | $1.3M 300,000 shares | -5% | - | |
| 31Weak | APLTsell Applied Therapeutics, Inc. | $572k 247,258 shares | -4% | - | |
| 34Weak | APLTsell Applied Therapeutics, Inc. | $781k 327,742 shares | -5% | - |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stockindirect: By subsidiary | -150,000 | $4.21 | $632k | 6,005,077 | Jun 6, 2024 |
| Jun 5, 2024 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stockindirect: By subsidiary | -150,000 | $4.24 | $636k | 5,855,077 | Jun 6, 2024 |
| Nov 29, 2023 | APLT Applied Therapeutics, Inc. | JOther Common Stockindirect: By subsidiary | +575,000 | - | - | 6,155,077 | Dec 1, 2023 |
| Nov 29, 2023 | APLT Applied Therapeutics, Inc. | JOther Common Stockindirect: By subsidiary | -575,000 | - | - | 203,977 | Dec 1, 2023 |
| Nov 2, 2023 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stockindirect: By subsidiary | -103,808 | $2.32 | $241k | 5,723,527 | Nov 6, 2023 |
| Nov 3, 2023 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stockindirect: By subsidiary | -143,450 | $2.31 | $331k | 5,580,077 | Nov 6, 2023 |
| Oct 31, 2023 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stockindirect: By subsidiary | -155,000 | $2.41 | $374k | 6,000,077 | Nov 2, 2023 |
| Nov 1, 2023 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stockindirect: By subsidiary | -172,742 | $2.36 | $408k | 5,827,335 | Nov 2, 2023 |
| Oct 12, 2023 | APLT Applied Therapeutics, Inc. | JOther Common Stockindirect: By subsidiary | +1,600,000 | - | - | 6,155,077 | Oct 16, 2023 |
| Oct 12, 2023 | APLT Applied Therapeutics, Inc. | JOther Common Stockindirect: By subsidiary | -1,600,000 | - | - | 778,977 | Oct 16, 2023 |
| Oct 12, 2023 | APLT Applied Therapeutics, Inc. | JOther Pre-Funded Warrantderivativeindirect: By subidiary | +615,000 | - | - | 1,500,000 | Oct 16, 2023 |
| Oct 12, 2023 | APLT Applied Therapeutics, Inc. | JOther Pre-Funded Warrantderivativeindirect: By subsidiary | -615,000 | - | - | 0 | Oct 16, 2023 |
Questions about Alexandria Real Estate Equities, Inc.
Answered from the filings on this page, as of the latest one.
Is Alexandria Real Estate Equities, Inc. buying or selling?
Not in the last 12 months. Alexandria Real Estate Equities, Inc.'s latest open-market trade on SEC Form 4 was sold $1.3M of APLT on Jun 4, 2024.
How did Alexandria Real Estate Equities, Inc.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alexandria Real Estate Equities, Inc. has 0.
Where does Alexandria Real Estate Equities, Inc. file Form 4?
Alexandria Real Estate Equities, Inc. has filed Form 4 at APLT (Applied Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.